Human Albumin Baxalta (Human Serum Albumin)

Human Albumin Baxalta is used in clinical settings where supplementation of albumin is required to restore oncotic pressure and support fluid balance. It is commonly employed in several medical situations.

• Treatment of hypoalbuminemia associated with chronic liver disease or nephrotic syndrome.
• Volume expansion in patients with hypovolemia due to burns, trauma, or surgery.
• Support of plasma volume during cardiopulmonary bypass or massive transfusion protocols.
• Adjunct therapy in patients with severe sepsis or septic shock to maintain circulatory stability.
• Replacement therapy in cases of congenital or acquired albumin deficiency.

• Human Serum Albumin acts as the principal plasma protein that maintains colloid osmotic pressure, thereby regulating fluid distribution between vascular and interstitial compartments. It also serves as a carrier for endogenous substances (e.g., fatty acids, hormones) and exogenous drugs, facilitating transport and modulating bioavailability. Intravenous infusion restores plasma albumin levels, helping to correct hypoalbuminemia and improve circulatory volume.

Adverse reactions to Human Albumin Baxalta can vary in frequency and severity.

Common

• Mild fever or chills
• Transient headache
• Nausea or vomiting
• Localized urticaria or rash at the infusion site
• Mild hypotension during infusion

Serious

• Anaphylactic or severe allergic reaction
• Pulmonary edema due to volume overload
• Acute hemolysis
• Severe hypotension requiring intervention
• Thromboembolic events such as deep‑vein thrombosis

Human Albumin Baxalta should be used with careful clinical assessment.

• Assess fluid status to avoid volume overload, especially in patients with heart failure or renal impairment.
• Monitor for signs of allergic reaction during and after infusion.
• Use caution in patients with severe pulmonary disease or compromised respiratory function.
• Evaluate coagulation parameters when administered with anticoagulants.
• Consider unknown pregnancy safety; use only if clearly needed.
• Store according to label instructions and discard any product that appears discolored or contaminated.

Human Albumin Baxalta may interact with other therapies that affect fluid balance or coagulation.

Avoid

• Simultaneous administration of other plasma expanders without appropriate monitoring.
• High‑dose diuretics that could precipitate rapid intravascular volume shifts.

Use with caution

• Anticoagulants (e.g., heparin, warfarin) – monitor coagulation status.
• ACE inhibitors or ARBs – watch for additive hypotensive effects.
• Vasopressors – adjust dosing based on hemodynamic response.
• Blood products – coordinate infusion rates to prevent circulatory overload.